Adenosine release in morphine-induced hypotension in rats

Area of Science:

• Pharmacology
• Neuroscience
• Cardiovascular Physiology

Background:

• Morphine administration is known to cause a reduction in mean arterial blood pressure (MABP).
• The precise mechanisms underlying morphine-induced hypotension, particularly the role of central pathways and neurotransmitters, require further elucidation.

Purpose of the Study:

• To investigate the role of adenosine receptors and nitric oxide pathways in morphine-induced hypotension.
• To explore the central mechanisms contributing to the hypotensive effects of morphine.

Main Methods:

• Intravenous administration of morphine hydrochloride and its analogues in an experimental model.
• Administration of theophylline, 8-phenyltheophylline, A1 and A2 adenosine receptor agonists, L-NG-Mono-methylarginine, dipyridamole, and tetrabenazine.
• Measurement of mean arterial blood pressure (MABP) to assess hypotensive effects.

Main Results:

• Intravenous morphine hydrochloride induced hypotension, while a quaternary analogue was ineffective.
• Theophylline and 8-phenyltheophylline attenuated morphine-induced hypotension.
• A2 adenosine receptor agonist caused hypotension, whereas A1 agonist was ineffective. L-NG-Mono-methylarginine partially reduced A2 agonist-induced hypotension but not morphine-induced hypotension.
• Dipyridamole enhanced morphine hypotension, while tetrabenazine abolished it.

Conclusions:

• The findings support a central hypotensive action of morphine.
• Adenosine release appears to play a significant role in mediating morphine-induced hypotension.
• These results highlight the complex interplay between opioid and adenosine systems in cardiovascular regulation.